Retrospective Cohort Study
Copyright ©The Author(s) 2023.
World J Gastroenterol. Mar 7, 2023; 29(9): 1509-1522
Published online Mar 7, 2023. doi: 10.3748/wjg.v29.i9.1509
Table 1 Compared the clinical and laboratory characteristics of the patients with low or high principal component score
Characteristics
Simple obstruction (n = 236)
P value
Strangulated obstruction (n = 45)
P value
Low PC score
High PC score
Low PC score
High PC score
Baseline data
Gender, n (%)1.00010.4212
    Male117 (69.2%)39 (69.6%)18 (52.9%)8 (72.7%)
    Female52 (30.8%)17 (30.4%)16 (47.1%)3 (27.3%)
Age (yr)60 (47, 69)65 (53, 71)0.08163 (52.25, 70.00)(61.0, 71.5)0.321
BMI (kg/m2)20.70 (18.83, 22.98)20.94 (18.21, 22.65)0.19620.20 (18.16, 22.00)18.75 (17.72, 19.81)0.228
Comorbidity, n (%)0.24511.0002
    None128 (75.7%)38 (67.9%)27 (79.4%)9 (81.8%)
    Yes41 (24.3%)18 (32.1%)7 (20.6%)2 (18.2%)
Pain duration (d)2 (1, 5)6 (3, 12.5)< 0.0002.00 (1.00, 3.75)2.0 (1.0, 4.0)0.989
History of abdominal operation, n (%)0.47110.6032
    None43 (25.4%)17 (30.4%)11 (32.4%)2 (18.2%)
    Yes126 (74.6)39 (69.6%)23 (67.6%)9 (81.8%)
Temperature (degrees Celsius)36.6 (36.5, 36.8)36.6 (36.5, 36.8)0.40136.6 (36.5, 36.8)36.60 (36.50, 36.75)0.956
CT characteristics
Mesenteric fluid (%)0.4300.9852
    None32 (18.9%)8 (14.3%)1 (2.9%)1 (9.1%)
    Yes137 (81.1%)48 (85.7%)33 (97.1%)10 (90.9%)
Ascites (%)0.8491.0002
    None58 (34.3%)20 (35.7%)4 (11.8%)1 (9.1%)
    Yes111 (65.7%)36 (64.3%)30 (88.2%)10 (90.9%)
Spiral signs (%)0.61220.4362
    None151 (89.3%)52 (92.9%)22 (64.7%)5 (45.5%)
    Yes18 (10.7%)4 (7.1%)12 (35.3%)6 (54.5%)
Concentric circle sign (%)0.13220.7452
    None164 (97.0%)51 (91.1%)31 (91.2%)11 (100%)
    Yes5 (3.0%)5 (8.9%)3 (8.8%)0 (0%)
Small bowel feces sign (%)0.0061.0002
    None70 (41.4%)35 (62.5%)17 (50.0%)5 (45.5%)
    Yes99 (58.6%)21 (37.5%)17 (50.0%)5 (54.5%)
Mural thickness (median)3.28 (2.30, 3.75)3.63 (2.97, 4.53)0.0023.51 (3.16, 4.12)3.42 (2.67, 4.07)0.634
Laboratory data
WBC (109/L)6.770 (4.89, 9.52)7.345 (4.87, 11.18)0.3878.70 (5.89, 12.23)6.83 (10.01, 18.25)0.384
NE%75.50 (65.9, 83.3)77.45 (68.5, 84.03)0.42283.60 (69.05, 86.90)77.50 (73.30, 90.25)0.853
Lymphocyte (109/L)1.01 (0.74, 1.42)0.94 (0.64, 1.34)0.2400.96 (0.65, 1.34)0.60 (0.42, 0.76)0.020
Monocyte (109/L)0.420 (0.30, 0.58)0.565 (0.34, 0.73)0.0110.570 (0.407, 0.735)0.540 (0.33, 0.760)0.721
NLR (ratio)4.650 (3.03, 8.07)6.115 (3.74, 9.30)0.1597.750 (4.085, 12.922)9.030 (4.990, 15.565)0.491
LMR (ratio)2.286 (1.67, 3.42)1.591 (1.13, 2.84)0.0021.681 (2.131, 1.141)1.482 (0.957, 1.933)0.459
Hb (g/L)128.0 (115, 142)120.5 (108, 133)0.016131.0 (110.0, 137.7)129.0 (120.5, 145.0)0.587
PLT (109/L)205.5 (162.50, 250.75)250.5 (180.25, 307.25)0.002213 (163, 260)180.0 (152.0, 242.5)0.256
Albumin (g/L)35.9 (32.30, 40.45)36.1 (31.80, 39.45)0.40334.6 (31.7, 39.6)37.1 (28.6, 42.0)0.977
ALT (U/L)16 (11, 24)16 (11, 22)0.72715.00 (12.00, 21.75)15.00 (13.25, 27.75)0.612
AST (U/L)20 (16, 26)21 (17, 25.5)0.61919.50 (17.00, 23.75)36.50 (20.75, 45.25)0.022
Ca (mmol/L)2.19 (2.04,2.32)2.15 (2.02,2.26)0.1522.19 (2.09, 2.31)2.05 (1.95, 2.20)0.062
Cl (mmol/L)102.30 (100.0, 104.1)100.15 (96.85, 104.03)0.015100.85 (98.13, 103.85)102.00 (101.35, 104.15)0.296
K (mmol/L)4.035 (3.78, 4.34)3.985 (3.74, 4.43)0.9574.00 (3.56, 4.31)4.36 (3.62, 5.07)0.290
Na (mmol/L)138.40 (136.68, 140.48)138.15 (135.50, 141.23)0.533138.05 (134.13, 140.30)135.60 (134.75, 137.75)0.334
BUN (mmol/L)5.5 (4.3, 7.2)5.4 (3.68, 8.23)0.8726.45 (4.00, 8.57)10.6 (7.3, 15.3)0.002
Glu (mmol/L)6.78 (5.30, 8.67)6.59 (5.16, 9.51)0.5158.165 (6.963, 9.300)8.66 (6.78, 11.04)0.428
PT (s)13.6 (13.1, 14.3)13.6 (13.28, 14.43)0.82513.45 (12.90, 13.90)15.40 (14.20, 16.65)0.004
APTT (s)35.6 (33.3, 38.3)36.1 (34.0, 40.9)0.18435.15 (32.18, 37.10)41.6 (36.1, 45.0)0.012
DDI (mg/L)1.45 (0.71, 2.52)1.94 (0.79, 4.67)0.1511.64 (0.88, 3.50)5.75 (2.39, 6.72)0.024
Fib (g/L)3.49 (2.92, 4.37)3.78 (3.25, 4.59)0.1503.69 (2.71, 4.60)3.89 (3.17, 4.82)0.548
Creatinine (umol/L)70.0 (56, 81)70.5 (54.75, 88.00)0.51267 (57, 76)93 (80, 147)0.003
Management< 0.00020.2152
    Conservative treatment155 (91.7%)17 (30.4%)1 (2.9%)0 (0%)
    Laparoscopy11 (6.5%)8 (14.3%)8 (23.5%)0 (0%)
    Laparotomy3 (1.8%)31 (55.4%)25 (73.5%)11 (100%)
CD, n (%)< 0.0002< 0.0002
    Grade I141 (83.4%)20 (35.7%)5 (14.7%)0 (0%)
    Grade II28 (16.6%)32 (57.1%)28 (82.4%)2 (18.2%)
    Grade III0 (0%)1 (1.8%)1 (2.9%)0 (0%)
    Grade IV0 (0%)3 (5.4%)0 (0%)9 (81.8%)
    Grade V0 (0%)0 (0%)0 (0%)0 (0%)
SAE, n (%)0.0182< 0.0002
    None169 (100%)53 (94.6%)34 (100%)2 (18.2%)
    Yes0 (0%)3 (5.4%)0 (0%)9 (81.8%)
Fee (¥)12070 (8830, 19935)54322 (41370, 74623)< 0.00051828 (33575, 66954)83553.0 (74146.0, 142409.5)< 0.000
Length of stay (d)5 (4, 8)16 (13.75, 22.50)< 0.00014.00 (10.25, 17.00)28.0 (18.5, 35.5)< 0.000
Table 2 Univariate and multivariate analyses of risk factors for high principal component score
Characteristics
Simple obstruction (n = 236)
Strangulated obstruction (n = 45)
Univariate
Multivariate
Univariate
Multivariate
OR (95%CI)
P value
OR (95%CI)
P value
OR (95%CI)
P value
OR (95%CI)
P value
Pain duration (d) 1.019 (1.002, 1.041)0.0481
Small bowel feces sign (+)/(-)0.424 (0.225, 0.783)0.00610.316 (0.158, 0.612)< 0.0001
Mural thickening (cm)2.119 (1.084, 4.375)0.03311.338 (1.098, 1.664)0.0031
Lymphocyte (109/L)0.097 (0.007, 0.665)0.03810.071 (0.003, 0.539)0.0331
Monocyte (109/L)5.472 (1.809, 17.780)0.0031
LMR (ratio)0.708 (0.541, 0.891)0.00610.656 (0.496, 0.836)0.0011
Hb (g/L)0.983 (0.969, 0.998)0.0331
PLT (109/L)1.003 (1.001, 1.007)0.0361
AST (U/L)1.075 (1.018, 1.156)0.0271
Cl (mmol/L)0.931 (0.871, 0.993)0.0311
BUN (mmol/L)1.383 (1.133, 1.786)0.00411.478 (1.169, 2.061)0.0041
PT (s)1.568 (1.141, 2.418)0.0151
APTT (s)1.109 (0.999, 1.264)0.076
DDI (mg/L)1.196 (1.006, 1.513)0.067
Creatinine (umol/L)1.034 (1.011, 1.071)0.0221